JP2020505075A5 - - Google Patents

Download PDF

Info

Publication number
JP2020505075A5
JP2020505075A5 JP2019561375A JP2019561375A JP2020505075A5 JP 2020505075 A5 JP2020505075 A5 JP 2020505075A5 JP 2019561375 A JP2019561375 A JP 2019561375A JP 2019561375 A JP2019561375 A JP 2019561375A JP 2020505075 A5 JP2020505075 A5 JP 2020505075A5
Authority
JP
Japan
Prior art keywords
cancer
seq
antigen
binding portion
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019561375A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020505075A (ja
JP7169296B2 (ja
Filing date
Publication date
Priority claimed from GBGB1701351.7A external-priority patent/GB201701351D0/en
Priority claimed from GBGB1713296.0A external-priority patent/GB201713296D0/en
Application filed filed Critical
Priority claimed from PCT/GB2018/050239 external-priority patent/WO2018138521A1/en
Publication of JP2020505075A publication Critical patent/JP2020505075A/ja
Publication of JP2020505075A5 publication Critical patent/JP2020505075A5/ja
Application granted granted Critical
Publication of JP7169296B2 publication Critical patent/JP7169296B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019561375A 2017-01-27 2018-01-26 結合剤 Active JP7169296B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB1701351.7A GB201701351D0 (en) 2017-01-27 2017-01-27 Binding agents
GB1701351.7 2017-01-27
GBGB1713296.0A GB201713296D0 (en) 2017-08-18 2017-08-18 Binding agents
GB1713296.0 2017-08-18
PCT/GB2018/050239 WO2018138521A1 (en) 2017-01-27 2018-01-26 Binding agents

Publications (3)

Publication Number Publication Date
JP2020505075A JP2020505075A (ja) 2020-02-20
JP2020505075A5 true JP2020505075A5 (https=) 2021-03-11
JP7169296B2 JP7169296B2 (ja) 2022-11-10

Family

ID=61132825

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019561375A Active JP7169296B2 (ja) 2017-01-27 2018-01-26 結合剤

Country Status (13)

Country Link
US (2) US10457736B2 (https=)
EP (1) EP3574013A1 (https=)
JP (1) JP7169296B2 (https=)
KR (1) KR20190112299A (https=)
CN (1) CN110475787A (https=)
AU (1) AU2018213124A1 (https=)
BR (1) BR112019015453A2 (https=)
CA (1) CA3051797A1 (https=)
IL (1) IL268288A (https=)
MX (1) MX2019008905A (https=)
RU (1) RU2019125975A (https=)
SG (1) SG11201906963QA (https=)
WO (1) WO2018138521A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102123322B1 (ko) 2019-11-01 2020-06-16 주식회사 미래에스엠 상판 오픈형 다용도 선반
KR20210132400A (ko) 2020-04-27 2021-11-04 유미경 다용도 선반
TW202246334A (zh) * 2021-02-02 2022-12-01 美商美國禮來大藥廠 Gitr拮抗劑及其使用方法
CN116782942A (zh) * 2021-02-02 2023-09-19 伊莱利利公司 Gitr拮抗剂和使用其的方法
EP4339209A4 (en) * 2021-05-10 2025-05-28 MediMabbio Inc. ANTI-GITR ANTIBODIES AND THEIR USES
US20240400671A1 (en) * 2021-10-05 2024-12-05 Richard A. Shimkets Monoconal antibodies to il-25 and uses thereof
IL314907A (en) 2022-03-15 2024-10-01 Yeda Res & Dev Antibodies against GITR and their uses
CN118050505B (zh) * 2024-04-15 2024-06-21 南京佰抗生物科技有限公司 一种多联检荧光免疫层析检测卡

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2343320T (pt) * 2005-03-25 2018-01-23 Gitr Inc Anticorpos anti-gitr e as suas utilizações
KR101790802B1 (ko) * 2009-09-03 2017-10-27 머크 샤프 앤드 돔 코포레이션 항-gitr 항체
TW201605896A (zh) * 2013-08-30 2016-02-16 安美基股份有限公司 Gitr抗原結合蛋白
SI3148579T1 (sl) * 2014-05-28 2021-07-30 Agenus Inc. Proti GITR antitelesa in postopki z njihovo uporabo
PE20170441A1 (es) * 2014-06-06 2017-04-26 Bristol Myers Squibb Co Anticuerpos contra el receptor del factor de necrosis tumoral inducido por glucocorticoides (gitr) y sus usos
MA41044A (fr) * 2014-10-08 2017-08-15 Novartis Ag Compositions et procédés d'utilisation pour une réponse immunitaire accrue et traitement contre le cancer

Similar Documents

Publication Publication Date Title
JP2020505075A5 (https=)
JP2017535257A5 (https=)
JP2020531048A5 (https=)
JP2020528750A5 (https=)
RU2014101669A (ru) Агенты, связывающие белки r-спондины (rspo), и способы их применения
JP2020534250A5 (https=)
JP2020501598A5 (https=)
JP2020536109A5 (https=)
JP2019535254A5 (ja) 抗pd−l1抗体および変異型
JP2021528400A5 (https=)
JP2010535713A5 (https=)
JP2015535828A5 (https=)
JP2019532056A5 (https=)
JP2014524902A5 (https=)
JP2017521054A5 (https=)
JP2013502913A5 (https=)
JP2017512759A5 (https=)
RU2013125306A (ru) Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование
JP2009505676A5 (https=)
RU2019125975A (ru) Связывающие агенты
JP2020514277A5 (https=)
RU2015142815A (ru) Лечение рака с использованием антител, связывающихся с поверхностным grp78
JP2020522281A5 (https=)
JP2020522280A5 (https=)
RU2019104980A (ru) Анти-icos антитела